• Lal Rehman, Urooj Lal Rehman, Rukhshanda Jabeen, and Raza Rizvi.
• Dr. Lal Rehman, FCPS (NS), MS (NS). Department of Neurosurgery, Jinnah Post Graduate Medical Centre/ Jinnah Sindh Medical University, Karachi, Pakistan.
• Pak J Med Sci. 2018 Mar 1; 34 (2): 412-417.

ObjectivesThe purpose of the study was to access the efficacy and response of the endoscopic transsphenoidal surgery in pituitary adenomas.MethodsIt was descriptive case study, conducted at Neurosurgery Department in collaboration with the Endocrine Unit (Medical Unit-II) Of Jinnah Post Graduate Medical Center Karachi from January 2015 to July 2017. Patients with sellar, supra sellar and para sellar tumors were enrolled in the study. Patients with prolactinoma and recurrent pituitary tumors were excluded. Data was analyzed using SPPS 17.ResultsSixty three patients were included in the study with mean age of 42±8.34 years. There were 40(63.5%) male patients and 23(36.5%) female patients with pituitary adenoma. Headache and visual impairment were the main presentation 55(87.3%) and 56 (88.8%) respectively. Out of all these patients the pituitary adenomas, 51(81%) patients had non secretory and 12 (19%) patients had secretory tumor. Out of these pituitary adenomas 53(84.1%) were macroadenomas and 10(15.9%) were microadenoma. Post operatively marked improvement in the headache was in all 100% patients and vision improved in 54 (96.4%). The most common post operative complication was cerebrospinal fluid (CSF) leak in 10 (15.9%) with 44 (69.8%) having no post complications at all. Mortality was reported to be just 1.6% i-e one patient.ConclusionThe endoscopic transsphenoidal approach for pituitary adenoma is the safest procedure with marked improvement in complications and reduction in patient's hospital stay.

3 keywords...

hide…